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Abstract

The pathophysiology of a traumatic brain injury (TBI) involves the dysfunction of the
blood-brain barrier (BBB). The lumen of the BBB is lined with cerebrovascular endothelial
cells (CVEC) that are ensheathed with perivascular astrocyte endfeet. We investigated the
cellular response of human-astrocytes and human-CVEC following trauma in vitro.
Astrocytes and CVEC were subjected to a concussive injury (CI; mechanical stretch), then
assessed for markers of injury (monolayer retraction) and activation (mitogen-activated
protein kinases (MAPK) phosphorylation).
CI induces astrocyte monolayer retraction and activation, with predominant
phosphorylation of JNK1/2 MAPK. Interfering with JNK1/2 activation (selective JNK
inhibitors) reduces trauma-induced astrocyte retraction. On the contrary, CI does not induce
CVEC retraction, however up-regulates CVEC pro-adhesive phenotype resulting in increased
polymorphonuclear leukocyte (PMN) adhesion.
These findings indicate that CI elicits differential BBB cell responses: JNK-mediated
astrocyte retraction and CVEC-dependent increase in leukocyte recruitment, the phenomena
that may contribute to overall BBB dysfunction following TBI.

Keywords
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Chapter 1

1

Introduction
Traumatic brain injury (TBI) remains to be one of the leading causes of

morbidity and mortality in children [1,2]. One component of the brain that may be
severely affected following TBI is the blood-brain barrier (BBB). The BBB plays an
integral role in the maintenance of homeostasis in the central nervous system and the
loss of its normal function can lead to secondary injury to the brain tissue [3]. Although
BBB dysfunction is suspected to be one of the pathological consequences of TBI, the
mechanisms are poorly understood.

1.1 Traumatic Brain Injury
Every year, millions of people in North America are hospitalized due to
traumatic injuries, with over 50 000 cases resulting in death [4]. At present, traumatic
injuries remain to be one leading cause of death in children in developed nations [1, 2].
A majority of children hospitalized from trauma suffer an injury to the head, or
traumatic brain injury (TBI) and 70% of the trauma-related deaths result from the
sustained head injury [2, 4].
Most TBIs occur from falls and motor vehicle collisions [4, 5]. Children and
adolescents are more likely to sustain a more severe TBI than adults due to their underdeveloped skulls, weaker necks, and larger head-to-body proportions [2, 4, 5]. A child’s
head is disproportionally larger relative to their body size, thereby making them more
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susceptible to a more severe brain injury from a given force of impact compared to an
adult [2]. Maturing skulls in children also contain less calcification, which provides less
protection to the brain tissue [4]. TBIs often have severe outcomes, including death and
long-term neurological deficits [6, 7]. The pathology of TBI is still not fully
understood, and only supportive treatments are available to reliably improve the longterm outcome for patients suffering from severe trauma.

1.2 Classification of TBI
TBI in patients are highly heterogeneous and depend largely on the type and
extent of the traumatic impact to the head. In general, TBI can be classified into two
groups: primary and secondary brain injuries [2]. The extent of the primary injury that a
person suffers following trauma depends on the magnitude and severity of the impact of
trauma that result in structural damage to the brain tissue [2, 5]. Trauma to the head
may result from a direct contact or impact loading - when the head comes in contact
with another object, or from a non-contact or inertia loading - when the brain
experiences rapid acceleration/deceleration motion in the skull [8]. The mechanical
strain produced by a TBI can be classified as comprehensive (reduced volume), shear
(application of torque, or rotation to a body) or tensile strain (increased length) [9]. The
force of impact and the resulting mechanical strain endured by the tissue determines the
extent of the primary injury. Primary traumatic brain injuries may include skull
fracture, contusion, lacerations, haematoma, diffuse axonal injury, and dural tears from
rapid acceleration/deceleration of the head [2,5, 8, 10]. A majority of pediatric trauma
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deaths occur shortly after impact due to the severity of the primary injuries sustained by
trauma [2].
Traumatic brain injured patients are also prone to suffer from complications
arising from their initial trauma, or secondary traumatic brain injuries [2]. Secondary
traumatic injuries may include hypoxia resulting from airway obstruction, hypotension
due to pulmonary dysfunction and blood loss, dysregulation of carbon dioxide, tissue
electrolyte imbalance, accumulation of neurotoxins, inflammation, brain swelling, and
increased intracranial pressure [2, 7, 10]. Insufficient management of secondary
complications can severely affect the brain tissue and worsen a TBI [2, 6, 11, 12].

1.3 Blood-brain Barrier
A major component of the brain that could be severely affected in a TBI is the
BBB. Neurons in the central nervous system (CNS) require a tightly regulated local
microenvironment for proper functioning [3, 13]. Maintenance of the CNS environment
depends on the BBB [3, 13]. The BBB is found in the microvasculature of the brain and
forms a physical barrier between the CNS and circulation [14]. In an average adult
human brain, the BBB represents 12-18m2 surface area of blood-brain exchange [14].
Functions of the BBB include separating central and peripheral pools of
neurotransmitters, regulating nutrient and ion exchange across the microvessel, and
excluding harmful molecules from entering the brain [14]. Many proteins found in the
blood, such as albumin and pro-thrombin can induce cellular activation and injury in
the brain parenchyma [14]. The BBB is also capable of protecting the CNS from
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circulating neurotoxins, whether endogenous or acquired from the environment [14].
Dysfunctional BBB may lose its ability to properly regulate the movement of
substances into the brain tissue, leading to further damage to the brain tissue.
The BBB is composed primarily of cerebrovascular endothelial cells (CVEC)
and astrocytes, with smaller numbers of pericytes, and pericytic macrophages [3].
These cells interact with one another as a functional unit that together give rise to the
unique features of the BBB. The luminal side of the BBB is lined with specialized
CVEC (Figure 1-1) [3, 13, 14]. These endothelial cells are unique from other
endothelial cells found in the peripheral parts of the body. CVEC act as the “physical
barrier” between the blood and the CNS, and restrict the movements of cells and
various molecules across the microvessels. CVEC develop intercellular tight junctions,
which contain high levels of occludin, claudin-5, and zonula-occluden protein 1 (ZO-1),
that restricts paracellular movements across the vessel and infer the characteristically
low permeability of the BBB [13]. Relative to peripheral capillaries, the cerebral
microvasculature are 50 to 100 times tighter [15]. In addition, CVEC lack cellular
fenestrae and essentially have no pinocytotic activity that together, further restricts
molecular transport across the endothelium [13, 16]. Small gaseous molecules (i.e. O2
and CO2) and lipophilic molecules can freely diffuse through the plasma membrane, but
most transcellular transport of nutrients, waste, and other hydrophilic molecules require
specific transport proteins on CVEC surface [13]. Thus CVECs of the BBB play an
essential role in regulating the exchange of substances between the blood and the CNS.
On the basolateral side of the endothelium, a basement membrane surrounds the
microvessels. (Figure 1-1). Beyond that, the BBB microvasculature is almost entirely
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covered by supporting astrocyte processes [17]. Perivascular astrocytes project their
specialized endfeet to surround the cerebral microvasculature (Figure 1-1) [13].
Astrocyte endfeet are in close contact with CVEC and are believed to induce key
characteristics of the endothelium and further enforce the low permeability of the
microvasculature [13, 16, 18]. They also are key mediators for cell-to-cell
communications between neurons and the microvessels [17]. Furthermore, overlapping
astrocyte processes covering the cerebral vasculature is also believed to play a
significant role control of localized blood flow and in restricting water influx into the
brain parenchyma [17]. There is an abundant expression of water channels, Aquaporin
4 (AQP4) on astrocytic endfeet that are involved in regulating ion and water
movements across the vasculature [13, 19]. Thus, astrocyte endfeet play a major role in
the proper functioning of the BBB [13, 16, 18, 19].
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Figure 1-1 Simplified Schematic Diagram of the Blood-brain Barrier. The bloodbrain barrier (BBB) is a specialized anatomical function found unique in the
microvasculature of the brain. Specialized cerebrovascular endothelial cells (CVEC)
line the lumen of the vasculature. A basement membrane surrounds the blood vessel,
which are subsequently ensheathed by the end-foot processes of perivascular astrocytes.
Together, they function to infer a low permeability of the blood vessel and restrict the
exchange of substances between the circulation and the brain parenchyma.
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1.4 Astrocyte-Endothelial Cell Coupling
Proper function of the BBB depends on intimate interactions between the
cellular components of the vasculature and of the CNS [13, 19]. Perivascular astrocytes
project their endfeet to almost entirely cover the basolateral side of the
microvasculature [13, 16, 19]. Typically, perivascular astrocytes and endothelial cells
are in constant communication and regulate the function of one another [13, 19]. In an
in vitro co-culture system, astrocytes can induce endothelial cells to express many
BBB-specific phenotypes, including the formation of more restrictive tight junctions, as
well as the expression and polarization of CVEC selective transporter proteins [13, 19].
Induction of BBB-specific characteristics depends on cell-cell contact and the release of
local mediators [15]. Astrocytes release a number of paracrine mediators, including
transforming growth factor-β (TGF-β), glial-derived neurotrophic factor (GDNF), basic
fibroblast growth factor (bFGF), and angiopoetin 1 (ANG1), that can induce endothelial
cells to express BBB phenotypes (Figure 1-2) [13, 15, 19]. In turn, endothelial cells can
also affect astrocyte phenotypes. In a co-culture, endothelial cells can stimulate
astrocytes to grow, polarize, and produce laminin – which forms a structure resembling
a basement membrane [15]. The disturbances or loss of astrocyte-endothelial
interactions may severely affect the integrity of the BBB. Several pathological
conditions have been associated with the disturbance between endothelial cells and glial
cell interactions [13]. For example, the capillaries in glial tumors exhibit increased
vascular permeability due to the lack of inductive factors secreted by astrocytes [13].
Perivascular astrocytes also function to mediate communication between
neurons and the vasculature [13, 19]. Together with CVEC, astrocytes associate with
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neurons to form a neurovascular unit to maintain proper blood flow in the capillaries to
maintain CNS homeostasis [13, 19]. Increased neural activity is accompanied by
increased in localized cerebral blood flow, known as functional hyperemia [20].
Functional coupling between neural activities and the response of the microvasculature
maintains the balance between energy supply and metabolic demand [15, 19].
During a synaptic activity, neurons communicate with astrocytes to signal the
endothelium for increased blood flow to supply oxygen, energy supply, and removal of
toxic by-products [15, 19]. Unlike larger blood vessels, the capillaries lack smooth
muscles for mediating vasodilation and vasoconstriction to regulate local blood flow.
Instead, dynamic changes in local capillary vasodilation/vasoconstriction are mediated
by perivascular astrocytes [15, 19, 20]. Within seconds of synaptic activities, there is a
transient wave of intracellular Ca2+ in astrocytes, which stimulates the release of
vasodilation/vasoconstriction factors [20]. These mediators include cyclooxygenase
(COX) 1 and 2 metabolites such as prostaglandin E2 (PGE2), epoxyeicosatrienoic acid
(EETs), nitric oxide (NO) and adenosine [20].
Furthermore, astrocytes are also involved in regulating glucose uptake across
the capillaries [15]. Neuronal activity up-regulates GLUT1 transporter activities on
perivascular astrocyte end-feet via Na+ and Ca2+ messenger pathways to increase
glucose availability for neurons (Figure 1-3) [15]. Functional hyperemia to match the
cerebral blood flow to the demand of neural activity occurs rapidly (within seconds)
and likely requires intimate contact between perivascular astrocyte endfeet and
endothelial cells [20]. Disruption of astrocyte-CVEC coupling can lead to the
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dysregulation of cerebral blood flow and further exacerbate a neurological pathology
[15, 19].
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Figure 1-2. Perivascular Astrocyte Induces BBB Phenotype in Endothelial Cells.
Astrocyte and endothelial cell coupling is important in the induction of BBB phenotype
in the brain capillaries. Astrocyte endfeet that are in contact with cerebral endothelial
cells release factors such as TGF-β, GDNF and bFGF to induce tightening of
intercellular tight junctions between endothelial cells, as well as expression and
polarization of selective protein transporters. Astrocytes are essential in inducing and
maintaining the low and selective permeability of the BBB [13, 15, 19].
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Figure 1-3 Role of Perivascular Astrocytes in Regulating Cerebral Blood Flow
(CBF). Astrocytes play an integral role in regulating capillary vasodilation and
vasoconstriction to supply neurons with proper energy supply. Upon neural activation,
there is a transient increase in intracellular Ca2+ that signals astrocytes to release
vasodilating or vasoconstricting factors such as PGE2, EET, NO and adenosine. Na+
and Ca2+ also up-regulates GLUT1 activities on astrocyte endfeet to facilitate glucose
transport across the vasculature. Thus the coupling of astrocyte endfeet to the
cerebrovasculature is essential in neural-vascular communication and regulating local
CBF for functional hyperemia [15, 19, 20].
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1.5 Pathology of TBI
Post-mortem examination of the brain of TBI victims reveal morphological
changes to the components of the BBB [21]. Assessment of human brains following
TBI revealed regions of reactive astrocytes and perivascular hemorrhage [18]. There are
also regions of enlarged perivascular space and swelling of astrocytes [21, 22].
Observations of injured brains revealed changes in perivascular astrocyte morphology.
These changes range from separation of astrocyte endfeet from the basement membrane
of the microvasculature to fragmented astrocytic processes with extensive areas of
capillary basement membranes absent of astrocyte coverage [21]. This suggests that
there are trauma-induced changes in perivascular astrocyte morphology, which may be
involved in the pathology of TBI.
Aside from the dysfunction associated from the mechanical impact of trauma,
the brain is also prone to the inflammatory effects of trauma that may worsen a TBI.
The CNS has long been considered to be an “immune privileged” site. Under a nonpathological condition, few immune cells are found in the brain parenchyma [3, 23].
The exclusion of circulating immune cells, such as polymorphonuclear leukocytes
(PMN) is largely due to the presence of the BBB. In rat models of TBI, there appears to
be an accumulation of PMN in the brain that correlates with the severity of posttraumatic injury [24, 25]. Overwhelming PMN infiltration in the brain may exacerbate
TBI by propagating neuroinflammation and contributing to the formation of edema
[24].
Recruitment of PMN in the brain following injury is likely facilitated by a
trauma-induced change in CVEC function. Under a normal physiological condition,
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CVEC of the BBB form a physical barrier that restricts PMN from entering the brain
parenchyma [3, 16, 24]. Traumatic injuries may induce up-regulation of enzymes (i.e.
matrix metalloproteinases) that can degrade the matrix components between cells,
thereby making the vessels “leaky” with increase its vascular permeability [26]. CVEC
may also increase the expression of surface adhesion molecules (i.e. E-selectin,
Vascular Cell Adhesion Molecule (VCAM), and Intercellular Cell Adhesion Molecule
(ICAM), which up-regulates CVEC interactions (e.g. rolling/adhesion) with circulating
PMN and facilitates PMN migration across the vasculature [11, 27, 28]. Although
neuroinflammation has been well documented following TBI [7, 11], PMN infiltration
into the brain in humans following traumatic injury remains unclear and continues to be
under investigations.

1.6 Astrocyte Cellular Response to Injury
Astrocytes project their endfeet over the basal membrane and surround the
entire vessel of the BBB (Figure 1-1) [16]. They come in close contact to CVECs and
are believed to be involved in the regulation of BBB function [13, 16]. Loss of contact
or uncoupling between the astrocyte-CVEC units may disrupt cell-cell communications,
which may lead to the dysfunction of the BBB.
The physical (mechanical) impact of TBI can severely affect the morphology
and function of astrocytes. Multiple studies have been conducted to study the effects of
TBI on astrocytes using in vivo animal models and in vitro stretch injuries, scratch
injuries, cell disruption techniques, and fluid percussion models using animal-derived
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cell culture [9, 26, 29, 30, 31, 32]. In an in vitro model of TBI, primary rat astrocytes
have exhibited increasing markers of injury correlating with greater stretch/concussive
injury [9]. Injured rat astrocytes exhibit the loss of plasma membrane integrity and a
change in cellular morphology [9]. Whereas uninjured rat astrocytes exhibit polygonal
shape and form confluent monolayers, moderately injured cells (30% stretch) became
swollen, and severely injured cells (55% stretch) retracted and became stellate-shaped
[9]. The changes in morphologies of injured rat astrocytes are also accompanied with
swelling of the mitochondria and destruction of astrocyte glial filaments [9. 33].
In addition to changes in cell morphologies, injured astrocytes may exhibit other
markers of cellular activation. A major focus has been on calcium-dependent astrocyte
response to stretch injury [34, 35]. Studies using rat astrocytes in vitro have reported
rapid and transient increase in intracellular calcium after stretch injury [32], along with
generation of free radicals [33, 36], nitric oxide production [33] and mitogen-activated
protein (MAP) kinase activation [33, 37]. Despite ongoing research, the pathology of
astrocyte injury following trauma and its contribution to the development of BBB
dysfunction and breakdown post-injury has yet to be explained.

1.7 CVEC Cellular Response to Injury
The luminal surface of the BBB is lined with CVEC that play a significant role
in maintaining the low permeability of the microvasculature [3]. These specialized
endothelial cells form the first barrier between the blood and the brain parenchyma, and
the loss of CVEC intercellular tight junctions, dysregulation of transcellular transport,
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and increased interactions with circulating immune cells can lead to an influx of
circulatory components into the CNS [1, 3, 27]. Disruption of the CVEC barrier may be
directly due to the impact force of trauma or as indirectly as a secondary consequence
mediated by neighbouring injured cells (i.e. astrocytes) [3].
Following a mechanical or biochemical insult, endothelial cells exhibit acute
responses that occur within minutes, which does not depend on de novo mRNA
expression and synthesis of new proteins [28]. Acute cellular response typically
involves protein modifications, such as phosphorylation of signaling molecules. Rapid
responses such as activation of signaling pathways can lead to a long term or delayed
change in cell phenotype. Delayed response to insults typically involves mRNA
transcription and synthesis of new proteins. In endothelial cells, a long-term or delayed
response to injury or stress typically includes expression of surface adhesion molecules
to facilitate interactions with circulating immune cells, secretion of local inflammatory
mediators and production of various growth factors [28].
A classic signaling pathway typically involved in endothelial cells following
stress or injury is the nuclear factor-κB (NF-κB) pathway. The transcription factor NFκB is activated by various stimuli including inflammatory factors such as tumornecrosis factor- (TNF-) α and β, interleukin- (IL-) 1β, as well as ROS and
lipopolysaccharide (LPS) [38]. NF-κB consists of multiple subunits: e.g. p50 and p65
and I-κB. In its inactive form, p50 and p65 (or their precursor p105/p100) form
complex with I-κB in the cytoplasm. Following activation, the I-κB becomes
phosphorylated, then subsequently ubiquitinylated and degraded, allowing p50 and p65
hetero- and/or homo-dimers to translocate to the nuclei where they can initiate
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transcription of the targeted genes [38]. Among the genes transcribed by activated NFκB include various inflammatory mediators (i.e. cytokines and chemokines) and
endothelial cell surface adhesion molecules [38, 39]. Other signal transduction
pathways known to be activated in response to stress and injury involves the mitogenactivated protein (MAP) kinase family.

1.8 MAP Kinase
One major signal transduction pathway that has been studied extensively in
various cell types and pathological conditions is the MAP kinase pathway. MAP
kinases respond to extracellular cues and induce an internal cellular response [40, 41].
MAP kinase responds to various stimuli, which includes cytokines, growth factors,
hormones, environmental stress and injury [41]. MAP kinases govern various cellular
functions, including various gene transcriptions, protein synthesis, cell growth,
differentiation and apoptosis [41].
In mammals, the three members of the MAP kinase family have been well
implicated in response to stress and injury: The Extracellular signal-regulated kinase
(ERK), the c-Jun NH2-terminal kinase (JNK) and the p38 MAP kinases. Studies have
reported the activation of ERK and p38 MAP kinases in response to traumatic injuries
in animal models [25, 33, 40, 42]. ERK and p38 are typically activated by stress and
cytokines [41].
The exact mechanism of signal transduction pathway from a mechanical injury
(i.e. concussion) to the activation of MAP kinase in astrocytes and CVEC is not fully
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understood. MAP kinase activation is regulated by a family of MAP kinase kinase
(MAP2K), which in turn is activated by a family of MAP kinase kinase kinase
(MAP3K) [41]. In injured cells, the MAP kinase signaling cascade may be initiated in
response to extracellular ATP (via P2Y G protein-coupled receptors), reactive oxygen
species (ROS), nitric oxide (NO), and intracellular Ca2+ wave– all of which markedly
increased following mechanical injury [33, 34, 35, 37, 43].
Following trauma, ERK and p38 activations lead to secretions of inflammatory
factors, up-regulation of matrix metalloproteinases (MMPs), and change in cellular
morphology [25, 33, 40, 42]. The JNK signaling pathway is activated in response to
environmental stress, toxins, ischemic reperfusion injury, pro-inflammatory cytokines,
and mechanical shear stress [41]. JNK activation can lead to a change in cell
morphology, secretions of inflammatory mediators, and cellular apoptosis [41]. MAP
kinase is also involved in regulating cell shapes and cytoskeleton stability through the
phosphorylation of actin- and microtubule-associated proteins [44]. Dynamic changes
to the cytoskeleton (i.e. actin assembly/disassembly) may be accompanied by the
modification of integrin-mediated focal adhesions [45, 46]. Integrin acts as a bridge
between actin cytoskeleton and extracellular matrix (ECM) protein for cell adhesion
[46]. Alterations of integrin-ligand density and organization affects cell surface
adhesion to ECM and facilitate in cell spreading and retraction [46].
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1.9 Rationale and Objective
Currently, the pathology of TBI is not fully understood, but trauma may
disrupt astrocyte and CVEC coupling that is critical for normal brain function.
Our study employed an in vitro model of the BBB using either primary human
astrocytes (HA) or a well-characterized immortalized human cerebral microvascular
endothelial cells (hCMEC/D3). By assessing the effects of trauma on astrocytes and
CVEC individually, we can further understand the role of each major component of the
BBB in the pathology of a TBI.
To simulate a TBI in vitro, the Cell Injury Controller II (Virginia
Commonwealth University Medical Center, Richmond, VA) delivers a regulated,
pressurized air pulse to culture wells that induces a biaxial stretch injury (i.e.
concussive injury) to cells grown on a flexible membrane. This type of injury mimics
both a concussive and stretch injury experienced by tissues during a rapid rotational
acceleration/deceleration head movement [9]. In this study, either HA or hCMEC/D3
monolayer was subjected to a single, 50 milliseconds, rapid stretch that translates to a
single concussive injury [9]. The TBI model employed in this study allows for a
homogenous and repeatable injury.
Clinical studies in patients with TBI revealed that concussive injury induces
morphological change in astrocytes (i.e. retraction of astrocyte endfeet from vascular
basement membrane) [21]. In parallel, an increase in PMN accumulation in rat brains
following injury has been demonstrated, suggesting increased PMN-CVEC adhesive
interactions [7, 24, 25] In our study, we aimed to determine the cellular responses of
either HA or hCMEC/D3 following a single concussive injury in vitro.
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Objectives:
(1) To determine whether a concussive injury induces changes in cellular morphology
of either HA or hCMEC/D3 monolayer.
(2) To determine the role of MAP kinases in HA and hCMEC/D3 response following a
concussive injury.
(3) To determine whether there is an up-regulation of pro-adhesive phenotype in
concussively injured hCMEC/D3.

Our study strictly employs the use of human tissues (ie. human astrocytes, human
CVEC, and human PMN), which may have a strong translational aspect to further
understand the pathology of TBI in humans, and can potentially lead to the
development of therapies for TBI patients.

1.10 Hypothesis
We hypothesize that:
1) Concussive injury induces morphological changes in either HA or hCMEC/D3.
2) Concussive injury induces activation of MAP kinases in HA and hCMEC/D3.
3) Concussive injury to hCMEC/D3 induces PMN adhesion
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Chapter 2

2

Methodology
We employed the use of either HA or hCMEC/D3 to assess for cellular response

following a concussive (i.e. mechanical) injury in vitro. We assessed for functional
changes induced by a severe concussive injury to cultured HA or hCMEC/D3, as well
as determining the underlying mechanisms involved in mediating cellular response
following injury.

2.1 Traumatic Brain Injury Model in vitro
An in vitro model of TBI was employed using the Cell Injury Controller II
(Virginia Commonwealth University Medical Center, Richmond, VA), an
electronically controlled pneumatic device capable of inducing regulated and repeatable
trauma to cell culture. The Cell Injury Controller II delivers a pulse of controlled gas
pressure to deform a flexible membrane fitted at the bottom of a commercially available
Bioflex® culture wells to induce a concussive injury in vitro (Flexcell International
Corp, Hillsborough, NC). In our experimental approach, the Cell Injury Controller II
delivered a 50-millisecond burst of gas into the culture well to induce a rapid membrane
deformation (Figure 2-1). The Cell Injury Controller allows for delivered pressure
adjustments to produce varying degrees if injury: “mild” (20% deformation with 1.8
peak PSI), “moderate” (35% deformation with 2.7 peak PSI) and “severe” (55%
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deformation with 4.0 peak PSI) concussive injuries. The amount of deformation
reported refers to the maximum percentage increase in surface area of the flexible
membrane as it stretched in response to the machine-delivered positive pressure in the
culture well. During the deformation of the membrane, cultured cells adhering to the
membrane surface experienced a biaxial stretch that translated to a mild, moderate, or
severe concussive injury (single hit), simulating a rotational, acceleration/decelerationtype trauma in vitro [9].
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Figure 2-1. Severe Concussive Injury modeling TBI in vitro. HA or hCMEC/D3
were grown on a fibronectin-coated flexible membranes of Bioflex® culture wells.
The Cell Injury Controller II delivers a positive pulse of air (measured as 4.0
PSI/well) into the culture well and deforms the flexible membrane (at 55% stretch).
In turn, cells adhering to the membrane experience a biaxial shear strain (or stretchtype injury) that translates to a “severe” concussive/traumatic injury.
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2.2 Human Astrocytes
Primary human astrocytes (HA; isolated from the cerebral cortex of a single
donor) were purchased from ScienCell™ Research Laboratories (Carlsbad, CA). HA
were grown on fibronectin-coated Bioflex® culture plate (Flexcell International Corp,
Hillsborough, NC) in VascuLife® cell culture medium supplemented with recombinant
human epidermal growth factor (5 ng/mL), L-glutamine (5 mM), ascorbic acid (50
µg/mL), fetal bovine serum (4%), penicillin (100 IU/mL) and streptomycin (100
µg/mL). HA were grown in 37°C with 5% CO2 until cell monolayer reaches
confluency. Passages 2-7 were used for experimentations.

2.3 Human Cerebrovascular Endothelial Cells
This study employs a stable, fully characterized immortalized human
cerebrovascular endothelial cell line, hCMEC/D3, provided to our lab by Dr. PierreOliver Couraud (INSERM, Paris, France). Briefly, primary human brain endothelial
cells were immortalized by lentiviral transduction of hTERT and SV40 large T antigen
as previously described [47]. hCMEC/D3 line exhibit phenotypes of fully-differentiated
primary human brain endothelial cells in vitro, including the capacity to up-regulate the
expression of surface adhesion molecules in response to inflammatory mediators,
formation of tight junctions between cells, and exclusion of drugs across a monolayer
[47, 48]. hCMEC/D3 were grown on fibronectin-coated Bioflex® culture plates
(Flexcell International Corp, Hillsborough, NC) in VascuLife® Endothelial Cell
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Growth Supplement (EnGS) cell culture medium supplemented with recombinant
human EnGS (0.2%), recombinant human epidermal growth factor (5 ng/mL), LGlutamine (10 mM), hydrocortisone hemisuccinate (1.0 µg/mL), heparin sulfate (0.75
µg/mL), ascorbic acid (50 µg/mL), fetal bovine serum (5 %), penicillin (100 IU/mL)
and streptomycin (100 µg/mL). hCMEC/D3 were grown in 37°C with 5% CO2 until the
cell monolayer reaches confluency.

2.4 Astrocyte Monolayer Retraction
Confluent HA grown on a fibronectin-coated Bioflex® plate form a dense cell
monolayer. Following a severe concussive injury, HA monolayer appears disrupted
with increased appearance of spaces between cells. To assess HA monolayer integrity
following a stretch injury, we designed an assay to allow us to quantify a monolayer
retraction. To do so, we selected a cell-permeable dye that would provide a uniform,
whole-cell staining of live cell culture.
HA grown on fibronectin-coated Bioflex® plate were pre-loaded with 20 µM
5,6-carboxyfluoroscein diacetate (CFDA; Molecular Probes, Eugene, OR) in
Vasculife® astrocyte culture medium for 30 minutes at 37°C. Following 2X wash with
warm PBS, cells received: (1) no injury, (2) mild injury (20% deformation), (3)
moderate injury (35% deformation) or (4) severe concussive injury (55% deformation),
and further incubated for another 30 minutes. Subsequently, images of the uninjured
and injured HA monolayers were captured by fluorescent microscopy (Zeiss Axiovert
200M Inverted Microscope; Carl Zeiss Canada Ltd., Toronto, Canada). 4 random fields
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of view for each treatment were captured at 33X magnification. Cell monolayer
retraction was assessed by quantifying the percentage of cell coverage in each image
measured by autothresholding the total surface area covered by cells (visible under
fluorescence) using an ImageJ software.

2.5 Quantification of Astrocyte Detachment
To determine whether there is significant HA detachment following severe
concussive injury, we quantified the number of cells present in the culture media
following a severe concussive injury. HA were grown on fibronectin-coated Bioflex®
culture well until the monolayer reached confluency. Cells were washed 1X with warm
PBS and placed in 300 µL of fresh culture media per well. HA were subjected to a
severe concussive injury (55% deformation) and incubated for 30 minutes at 37°C.
Subsequently, the culture media from triplicate wells of uninjured and injured HA were
collected into microtubes. Uninjured and injured cell media samples were centrifuged at
20 000 g for 10 minutes and each pellets were resuspended in 75µL of cold PBS. Cells
were placed in a much smaller volume (12X concentrated) relative to the original
sample volume to allow for a more accurate cell counting. The number of cells in each
sample was counted using a Haemocytometer (Hausser Scientific, Horsham, PA) and
expressed as the number of cells detached per monolayer.
To determine the total number of HA in a confluent monolayer, confluent cells
were fixed in 3% paraformaldehyde (PFA; Bioshop Canada Inc, Burlington, Canada) in
PBS for 15 minutes and permeabilized in 0.1% Triton X-100 (Sigma Aldrich, St. Louis,
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MO) in PBS for 10 minutes. Cellular nuclei were stained with Hoechst 33342 nuclear
stain (Molecular Probes, Eugene, OR) for 2 minutes and images were captured by
fluorescent microscopy (Zeiss Axiovert 200M Inverted Microscope; Carl Zeiss Canada
Ltd., Toronto, Canada). The number of cells (with respect to the number of nuclei) in a
10 000 µm2 field of view were counted from 4 confluent HA monolayers to determine
the total number of cells on one a Bioflex® culture well (1.96 cm2 growth area per
well).

2.6 MAP Kinase Activation Following Severe Injury
Activations of MAP kinases, ERK, JNK and p38 were assessed by phosphoERK 1/2, phospho-JNK 1/2 and phospho-p38 Western blotting. Confluent HA or
hCMEC/D3 were grown on fibronectin-coated Bioflex® plate. Uninjured and severely
injured cells were incubated for 30 minutes, then washed with cold PBS supplemented
with 0.4 mM sodium orthovanadate (Sigma-Aldrich, St. Louis, MO), a phosphatase
inhibitor. Following the wash, cells were lysed in 200 µL hot sodium dodecyl sulfate
(SDS)-electrophoresis sample buffer. Samples were sonicated, then boiled for 5
minutes at 95°C. Uninjured and injured cell samples were then subjected to a 12%
SDS-polyacrylamide gel electrophoresis (PAGE), and proteins were transferred
overnight to a BioTrace™ polyvinylidene difluoride (PVDF) membrane (Pall
Corporation, Port Washington, NY).
The membranes were blocked in 5% skim milk with 0.1% Tween in trisbuffered saline (TBS) for 1 hour. Then, they were incubated for 1 hour at room
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temperature with mouse monoclonal antibody against phospho-ERK1+ERK2 (Clone
MAPK-YT; Abcam Inc., Cambridge, UK), rabbit polyclonal antibody against phosphoJNK1+JNK2 (Abcam Inc., Cambridge, UK) or rabbit monoclonal antibody against
phospho-p38 (Clone E229; Abcam Inc., Cambridge, UK) in 2% skim milk in TBS. The
membranes were then incubated with corresponding horseradish peroxidase (HRP)conjugated secondary antibodies (Invitrogen, Carlsbad, CA) in 2% skim milk in TBS.
For the protein loading control, membranes were also probed with mouse monoclonal
antibody against Glyceraldehyde-3-phosphate dehydrogenanse (GAPDH; Clone 6C5;
Abcam Inc., Cambridge, UK). Levels of phospho-ERK, JNK, and p38 proteins were
standardized to GAPDH rather than its corresponding total MAP Kinase protein levels
to avoid membrane stripping and loss of protein signal quality associated with the latter
technique. Bound target antibodies were visualized using enhanced chemiluminescence
detection (2.5 mM Luminol, 0.4 mM p-Coumaric acid, 0.02% hydrogen peroxide in
100 mM Tris buffer; Sigma-Aldrich, St. Louis, MO). Images of the immunoblots were
captured using a MicroChemi imaging system (FroggaBio, Toronto, Canada) and band
quantifications were done using GelQuant Pro Software (FroggaBio, Toronto, Canada).

2.7 JNK Inhibitors
To determine whether there is a link between JNK 1/2 activations in HA with
monolayer retraction, changes in injured HA morphology was assessed in the presence
of JNK inhibitors. We employed two commercially available JNK inhibitors, SP600125
(Sigma Aldrich, St. Louis, MO) and SU3327 (Tocris Bioscience, Bristol, UK).
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SP600125 is a cell permeable, selective inhibitor of JNK-1, -2 and -3, and has been
widely used with various cell types [42, 49, 50]. SP600125 is a reversible, adenosine
triphosphate (ATP) competitive inhibitor [51], which prevents JNK activation by
blocking the ATP binding site on the JNK molecule [52]. SU3327 is a more recently
developed selective, competitive JNK inhibitor that prevents protein-protein
interactions between JNK and JNK Interacting Protein (JIP) [53], a scaffold protein
responsible for regulating JNK signaling [41].
HA monolayer retraction was assessed as described above. Following CFDA
staining, cells were washed with warm PBS and placed in fresh culture medium. Cells
treated with the JNK inhibitors were supplemented with 25µM of SP600125 or
SU3327. The concentrations of JNK inhibitors were selected according to currently
published literatures that closely resemble our experimental settings [33, 42, 51, 52,
53]. HA were incubated with the JNK inhibitors for 10 minutes prior to injury.
Monolayer retraction in HA with or without the JNK inhibitors were assessed 30
minutes following a severe concussive injury.

2.8

Assessment of Endothelial Cell Pro-adhesive
Phenotype
Human polymorphonuclear leukocytes (PMN) were isolated from venous blood

of a healthy adult donor immediately prior to each experiment. 10 milliliters of whole
blood was collected into a syringe supplemented with 10 U/mL heparin (Leo Pharma
Inc., Thornhill, Canada) and transferred into 5 mL of 3% Dextran in phosphate buffered
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saline (PBS) to give a final concentration of 1% Dextran/blood mixture. The mixture
was gently inverted 10 times to allow even mixing, followed by a 25 minutes rest at
room temperature to allow for red blood cell sedimentation. The PMN-containing upper
blood plasma fraction was then transferred and layered on top of 5 mL leukocyte
separation medium (1.077 g/mL density Histopaque®-1077; Sigma-Aldrich, St. Louis,
MO). Samples were then centrifuged at 400g for 30 minutes at 4°C. Following
centrifugation, the supernatant was aspirated, and the PMN-containing pellet was
resuspended in 15 mL cold hypotonic buffer to lyse remaining red blood cells (8.30 g/L
NH4Cl, 1 g/L KHCO3, 0.14 mM EDTA; pH 7.2). Following a 5 minutes incubation on
ice, samples were centrifuged at 320 g for 5 minutes at 4°C. The supernatant was once
again aspirated, and the PMN pellet was resuspended in 1 mL cold PBS. The number of
PMN recovered was counted using a hemacytometer (Hausser Scientific, Horsham, PA)
and cells were kept on ice until immediately before use.
Freshly isolated PMN were labeled with radioactive probe, Chromium-51. Five
µCi of Chromium-51 (51Cr; CJS4, CJS11, Amersham Plc, Buckinghamshire, UK) were
added per 1 X 106 PMN in PBS enriched with 1 mM glucose and incubated at room
temperature for 40 minutes. 51Cr-labelled PMN (51Cr-PMN) were washed 2X and
resuspended in cold PBS, then kept on ice until use.
Confluent hCMEC/D3 grown on fibronectin-coated Bioflex® in Vasculife®
culture medium were subjected to no injury or severe concussive injury and incubated
for 4 hours. Subsequently, hCMEC/D3 were washed 1X with warm culture medium
and received fresh culture medium. 51Cr-PMN (1 X106 cells/well) were added to the
hCMEC/D3 monolayer, and cells were further incubated for another 30 minutes at
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37°C. Following incubation, cells were washed with warm PBS to remove nonadhering 51Cr-PMN. Remaining cells in the well were lysed with 1M NaOH.
Radioactivity levels in the cell lysate samples were measured using an automatic
gamma ray counter (Wallac 1480 Wizard™ 3”; Turku, Finland). PMN adhesion to
hCMEC/D3 monolayer was presented as percent of PMN adhesion (% CPM in sample
relative to total 51Cr-PMN CPM added).

2.9 NF-κB Activation
The relative activation of NF-κB in hCMEC/D3 following severe concussive
injury was assessed using a PathScan® Phospho-NF-κB p65 (Ser536) Sandwich ELISA
kit (Cell Signaling Technology, Inc., Danvers, MA). The assay was performed
according to the protocol provided by the manufacturer. Confluent hCMEC/D3 grown
on fibronectin-coated plastic culture well plate were subjected to a severe concussive
injury and incubated for 1 hour. Subsequently, cells were washed with cold PBS and
lysed with 1x Cell Lysis Buffer (provided by manufacturer) plus 1mM PefaBloc® SC
(Sigma-Aldrich, St. Louis, MO). Cell lysates were sonicated, and following a 10 minute
20 000g centrifugation, the sample supernatant were retained. 50 µL of each sample
was diluted at 1:1 ratio with a Sample Diluent provided in the kit, and transferred into a
Phospho-NF-κB p65-antibody coated-microwell. The microwell plate was incubated
overnight at 4°C. Following incubation, the contents of the plate were discarded and the
wells were washed 4X with a Wash Buffer (from kit). 100 µL of detection antibody was
added into each microwell and the plate was incubated for 1 hour at 37°C.
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Subsequently, the detection antibody was removed and the wells were washed 4X with
Washing Buffer. 100 µL of HRP-linked antibody was then added into each microwell
and the plate was incubated for 30 minutes at 37°C. The contents in the plate were
removed and the wells were washed 4X with Washing Buffer. Lastly, 100 µL of TMB
substrate was added into each microwell, and following 10 minutes of incubation at
37°C, 100 µL of STOP Solution was added per well. Results of the assay were
measured spectrophotometrically using a Bio-Rad 680 Microplate Reader (Bio-Rad
Laboratories, Hercules, CA). The absorbance was read at 450 nm and expressed as
optical density (O.D) measured. The value of O.D. corresponds to levels of phosphoNF-κB p65 detected in each sample.
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Results
Either HA or hCMEC/D3 monolayers were subjected to concussive injury in

vitro and assessed for changes in cellular morphology with respect to cellular retraction.
MAP kinase activation in HA and hCMEC/D3 were assessed using Western blots of
phosphorylated JNK 1/2, ERK 1/2, and p38. Severe concussive injury to HA appeared
to induce JNK 1/2 activation at 30 minutes post-injury, which correlates to the
appearance of monolayer retraction (Figures 3-1 to 3-8). Selective JNK inhibitors were
employed to determine the role of JNK 1/2 in mediating injury-induced HA monolayer
retraction (Figures 3-9 to 3-10).
Unlike HA, hCMEC/D3 monolayer does not appear to be affected by a severe
concussive injury with respect to its cellular morphology (Figure 3-1). To investigate
other aspects in which hCMEC/D3 respond to severe concussive injury, we assessed
whether there is increased PMN adhesion to injured hCMEC/D3 using radioactivelabeled PMN (Figure 3-11). Furthermore, we assessed whether MAP kinase and NFκB are also involved in mediating CVEC response to a concussive injury (Figure 3-12
to 3-15).
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3.1 Cellular Morphologies Following Severe Concussive
Injury
HA grown on fibronectin-coated coated Bioflex® plate forms a tight, confluent
monolayer with little to no gaps between cells. Similarly, hCMEC/D3 also form a tight
monolayer on the fibronectin-coated coated Bioflex® plate. In our study, either HA or
hCMEC/D3 were subjected to “severe” concussive injury (55% deformation). At 30
minutes following the same degree of stretch, the appearance of HA and hCMEC/D3
monolayers were strikingly different. HA monolayer appears to be retracted with visible
gaps between cells. In contrast, hCMEC/D3 monolayer remains fully intact (Figure 31).
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Figure 3-1. Images of hCMEC/D3 and HA Monolayers Following Severe
Concussive Injury. Cell monolayer images were captured using light microscopy (50X
magnification) at 30 minutes following stretch injury. Top panel depicts uninjured cells
for comparisons. No obvious changes are observed in the appearance of injured
hCMEC/D3 monolayer compared to uninjured cells. In contrast, concussively injured
HA monolayer appears retracted with increased intercellular spaces between astrocytes.
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3.2 Quantification of HA Monolayer Retraction
To quantify the level of HA retraction, we compared images of fluorescentstained HA following injury with uninjured HA monolayer. From a given image, the
ImageJ software automatically measures the surface area covered by cells (light area)
relative to the dark background (no cells). The percent of surface area occupied by cells
were then calculated to provide a quantitative value of monolayer retraction. The lower
the area “occupied by cells”, the greater the monolayer retraction.
Uninjured HA formed a tightly packed cell monolayer with little spaces
between cells (Figure 3-2a). This translates to a higher value for the percent of surface
covered by cells (i.e. monolayer coverage area). Following a severe concussive injury
(55% deformation) HA retract and form large gaps between cells (Figure 3-2b).
Therefore, cells would occupy less area in a given surface dimension. Our data
indicated that a severe concussive injury (55% deformation) to HA results in monolayer
retraction, represented by a decrease in the percentage of area covered by stained cells
(Figure 3-2c; n=4, * indicates P<0.05 according to Mann-Whitney Rank Sum Test).
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a)

b)

c)

Figure 3-2 HA Monolayer Retraction following a Severe Concussive Injury. HA
were pre-incubated with 5, 6-carboxyfluoroscein diacetate (CFDA, 20 µM) and
subjected to no injury or severe concussive injury. Fluorescent images of uninjured (a)
and injured (b) cell monolayer were captured 30 minutes later. The monolayer
retraction was assessed by the quantification of the area covered by the fluorescentstained HA. (c) Severe concussive injury to HA resulted in monolayer retraction,
represented by the decrease in the percentage of area covered by cells (mean±SEM,
n=4, * indicates P < 0.05 according to Mann-Whitney Rank Sum test). Data were
collected from 4 independent experiments, each done in duplicate wells.
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3.3 HA Retraction Depends on Severity of Injury
To determine whether HA monolayer retraction varies with the severity of
concussive injury, we assessed for monolayer retraction of HA following a mild (20%
deformation), moderate (35% deformation) and severe (55% deformation) concussive
injury. Quantification of HA monolayer retraction at 30 minutes following injury
revealed that HA monolayer integrity is significantly reduced following a severe
concussive injury, but not in mild or moderately injured cells (Figure 3-3; n=5, * and
** indicates P < 0.05 and P < 0.01, respectively, according to One Way ANOVA and
Tukey’s Post Hoc Test). HA monolayer subjected to a severe concussive injury had a
significantly lower percentage of monolayer coverage area than moderately injured
cells (i.e. more retraction). Thus, HA retraction depends on the degree of injury
inflicted upon the cells, and requires a severe concussive injury to induce monolayer
retraction.
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Figure 3-3. HA Monolayer Retraction Following Mild, Moderate and Severe
Concussive Injury. HA were pre-incubated with 5, 6-carboxyfluoroscein diacetate
(CFDA, 20 µM) and subjected to no injury, mild (20% deformation), moderate (35%
deformation) and severe (55% deformation) concussive injury. Fluorescent images of
cell monolayers were captured 30 minutes later. The monolayer retraction was
assessed by the quantification of the area covered by the fluorescent-stained astrocytes
(mean±SEM, n=5, * indicates P < 0.05 and ** indicates P < 0.01 according to One
Way ANOVA and Tukey’s Post Hoc Test). Data were collected from 5 independent
experiments, each done in duplicate wells.
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3.4 HA Retraction is not Due to Cell Detachment
To confirm that the increased gaps between HA following severe concussive
injury is due to cellular retraction, and not cellular detachments, we quantified the
number of cells in cell media following injury. Our data revealed that there are about
365 and 375 cells per monolayer in the uninjured and injured cell media, respectively
(Figure 3-4; n=3). There is an average of 335 400 cells in a confluent monolayer per
well, so the number of cells detected in the media account for about 0.1% of the total
number of cells per well. Therefore, cellular detachment from HA monolayer does not
contribute to the appearance of intercellular gaps following severe concussive injury.
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Figure 3-4. HA Detachment from Monolayer Following Severe Concussive
Injury. Cell media of uninjured and severely concussed HA monolayer were
collected at 30 minutes post-injury. The number of cells in the media was counted
using a Haemocytometer and provided the number of cells detached from uninjured
and injured HA monolayer (mean ±SEM; n=3). The amounts of detached cells from
uninjured and injured monolayer were not significantly different from one another.
Data were collected from 3 independent experiments.
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3.5 MAP Kinase Activation in HA
To assess for which signaling pathway is involved in concussively-injured cells,
we assessed for activations of MAP Kinase by measuring the levels of phosphorylated
JNK 1/2, ERK 1/2, and p38 proteins in uninjured and severely injured HA and
hCMEC/D3. Detected Western blots of JNK 1/2, ERK 1/2, and p38 were quantified and
standardized to GAPDH levels in the samples, presented as the optical density (O.D.) of
phospho-JNK 1/2, -ERK 1/2 and -p38 over GAPDH. Representative bands from 3
independent experiments are shown in Figure 3-5.
Assessment of phosphorylated JNK 1 and 2 levels indicate that JNK 1/2 are
activated in HA at 30 minutes following a severe concussive injury (Figure 3-6).
Quantification of JNK 1/2 immunoblots revealed that there was almost a 3-fold increase
in the levels of phosphorylated JNK 1/2 in injured HA relative to uninjured cells
(Figure 3-6; n=6, * indicates P < 0.05 according to student t-test). There was also a
moderate, however significant increase in the levels of phosphorylated ERK 1 in
injured HA relative to uninjured cells (Figure 3.7; n=10, * indicates P < 0.05),
suggesting a concussive injury-induced ERK 1 activation. Levels of phospho-ERK 2
(Figure 3-7; n=10) and phospho-p38 (Figure 3-8; n=6) were not significantly higher in
injured HA relative to uninjured HA, which suggest that ERK 2 and p38 are not
activated in HA following a severe concussive injury.
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Figure 3-5. MAP Kinase Phosphorylation in HA. Uninjured and severely-injured HA
were lysed in 1X SDS sample buffer at 30 minutes post-injury and subsequently
subjected to SDS-PAGE. Proteins were transferred by Western blotting onto a PVDF
membrane and probed with antibodies against phosphorylated JNK 1/2 (p-JNK 1/2),
phosphorylated ERK 1/2 (p-ERK 1/2) or phosphorylated p38 (p-p38). GAPDH served
as

loading

control.

Protein

bands

were

visualized

by

chemiluminescence.

Representative immunoblots from 3 independent experiments are shown above.
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Figure 3-6. Levels of phosphorylated JNK 1/2 in HA Following Severe
Concussive Injury. Western blotting was performed to detect levels of
phosphorylated JNK 1/2 (p-JNK 1/2) in uninjured and severely concussed HA at 30
minutes post-injury. Protein bands corresponding to p-JNK 1/2 were quantified and
standardized to the levels of the loading control protein, GAPDH. Relative levels of pJNK1/2 are presented as the optical density (O.D.) of p-JNK 1/2 over GAPDH. Levels
of p-JNK 1/2 are significantly higher in injured HA compared to uninjured cells
(mean±SEM, n=6, * indicates P < 0.05 according to student t-test). Data were
collected from 6 independent experiments.
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Figure 3-7. Levels of phosphorylated ERK 1/2 in HA Following Severe
Concussive Injury. Western blotting was performed to detect levels of
phosphorylated ERK 1/2 (p-ERK 1/2) in uninjured and severely concussed HA at 30
minutes post-injury. Protein bands corresponding to p-ERK 1/2 were quantified and
standardized to the levels of the loading control protein, GAPDH. Relative levels of pERK 1/2 are presented as the optical density (O.D.) of p-ERK 1/2 over GAPDH.
There is a significant increase in p-ERK 1 in injured HA relative to uninjured cells
(mean±SEM, n=10, * indicates P < 0.05 according to Mann-Whitney Rank Sum test).
Data were collected from 10 independent experiments.

45

Figure 3-8. Levels of phosphorylated p38 in HA Following Severe Concussive
Injury. Western blotting was performed to detect levels of phosphorylated p38
(p-p38) in uninjured and severely concussed HA at 30 minutes post-injury.
Protein bands corresponding to p-p38 were quantified and standardized to the
levels of the loading control protein, GAPDH. Relative levels of p-p38 are
presented as the optical density (O.D.) of p-p38 over GAPDH (mean±SEM, n=6).
Data were collected from 6 independent experiments.
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3.6 JNK Inhibitors Block HA Retraction Following Severe
Concussive Injury
Our findings revealed that severe concussive injury induces an almost 3-fold
increase in phosphorylated JNK 1/2, suggesting a JNK 1/2 activation following injury.
To assess whether JNK activation is an associated mechanism for mediating HA
monolayer retraction following a severe concussive injury, we employed 2 structurally
distinct selective JNK inhibitors: SP600125 and SU3327. HA were pre-treated with 25
µM of SP600125 or SU3327 for 10 minutes prior to injury. HA retraction was assessed
with CFDA-stained astrocytes, as described above.
Similar to the previous experiments, application of severe concussive injury to
HA monolayer resulted in cellular retraction, with respect to percent of surface area
covered by cells. However, pre-treatment with JNK inhibitor, SP600125 reduces the
extent of retraction such that HA pre-treated with SP600125 had some monolayer
retractions following injury compared to uninjured cells, but the cellular retractions
were not as severe as those that were injured without SP600125 (Figure 3-9; n=6 * and
** indicates P < 0.05 or <0.01, respectively, according to One Way ANOVA and
Tukey’s Post-hoc test). Monolayer retraction of uninjured and injured HA that were
both pre-treated with SP600125 were not significantly different.
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Figure 3-9. HA Monolayer Retraction with SP600125 Pre-treatment. Confluent
HA were stained with 5,6-CFDA and pre-treated with 25 µM of SP600125 for 10
minutes prior to a severe concussive injury. Fluorescent images of HA monolayers
were captured at 30 minutes following injury, and the monolayer retraction was
presented as the percent of surface area covered by cells. In the absence of
inhibitors, severe concussive injury induces monolayer retraction. HA pre-treated
with SP600125 exhibited less monolayer retraction than the cells injured in the
absence of JNK inhibitor (mean±SEM; n=6, * and ** indicates P < 0.05 or < 0.01,
respectively, according to One Way ANOVA and Tukey’s Post-Hoc test). Data
were collected from 6 independent experiments, each done in duplicate wells.
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To confirm our findings, we employed a second selective JNK inhibitor,
SU3327, to assess whether inhibition of JNK 1/2 blocks concussively injured HA
monolayer retraction. Again, severe concussive injury induces HA monolayer retraction
compared to uninjured cells. HA monolayer pre-treated with SU3327 did not exhibit
any significant monolayer retraction relative to uninjured cells, suggesting that
inhibiting JNK blocks HA retraction following a severe concussive injury (Figure 310; n=5, * and ** indicates P < 0.05 or < 0.01, respectively, according to One Way
ANOVA and Tukey’s Post-hoc Test).
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Figure 3-10. HA Monolayer Retraction with SU3327 Pre-Treatment. Confluent
HA were stained with 5,6-CFDA and pre-treated with 25 µM of SU3327 for 10
minutes prior to a severe concussive injury. Fluorescent images of HA monolayers
were captured at 30 minutes following injury, and monolayer retraction was presented
as the percent of surface area covered by HA. In the absence of inhibitors, concussive
injury reduced HA monolayer integrity. HA monolayer integrity for cells pre-treated
with SU3327 were not significantly lower than uninjured cells, suggesting that JNK
inhibition blocks HA monolayer retraction (mean±SEM; n=5, * and ** indicates P <
0.05 or < 0.01, respectively, according to One Way ANOVA and Tukey’s Post-Hoc
Test). Data were collected from 5 independent experiments, each done in duplicates.
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3.7 Concussive Injury Up-regulates hCMEC/D3 Proadhesive Phenotype
Unlike HA, severe concussive injury (55% deformation) does not induce
apparent change in hCMEC/D3 cellular morphology (Figure 3-1). Thus we assessed
for other aspects of how stretch injury affects CVEC. Animal models of TBI reported
PMN accumulations in the brain following trauma, which likely involves the upregulation of CVEC pro-adhesive phenotype [7, 11, 24, 25]. Therefore, we assessed for
PMN adhesive interactions with hCMEC/D3 monolayer under “static” condition after a
severe concussive injury. Data from our study revealed that there was an almost 2-fold
significantly larger amount of PMN adhering to injured hCMEC/D3 monolayer relative
to uninjured cells at 4 hours following injury (Figure 3-11; n=6, * indicates P < 0.05,
according to student t-test).
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Figure 3-11. PMN Leukocyte Adhesion to Injured hCMEC/D3 Monolayer. 51Cr
labeled PMN were added to hCMEC/D3 monolayer (5:1 PMN/hCMEC/D3 ratio)
for 30 minutes at 4 hours following injury. Injured hCMEC/D3 monolayer had a
significantly higher amount of adhering PMN relative to uninjured cell monolayer
(mean±SEM, n=6, * indicates P < 0.05 according to student t-test). Data were
collected from 6 independent experiments, each done in duplicate wells.
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3.8 MAP Kinase Not Activated in Injured hCMEC/D3
Our assessment of PMN adhesion to injured hCMEC/D3 monolayer indicates
that a severe concussive injury induces the up-regulation of pro-adhesive phenotype in
CVEC. Subsequently, we assessed whether the injury-induced cellular response in
hCMEC/D3 is regulated by MAP kinase activation. We measured levels of phosphoJNK 1/2 (p-JNK 1/2), phospho-ERK 1/2 (p-ERK1/2), and phospho-p38 (p-p38) in
uninjured and injured hCMEC/D3 at 30 minutes following a severe concussive injury.
Similar to the HA experiments, levels of the phosphorylated MAP kinase proteins
detected were standardized to GAPDH serving as protein loading control. For a positive
assay control, samples of hCMEC/D3 treated with a known MAP kinase inducer
(Cytomix; CM: 10 ng/mL TNF-α, IL-1β, and IFN-γ) were loaded in parallel to the
uninjured and injured cells. Detected Western blots of ERK 1/2 and p38 were
quantified and standardized to GAPDH levels in the samples, presented as the optical
density (O.D.) of phospho-ERK 1/2 and -p38 over GAPDH. Representative images
from 3 independent experiments are shown in Figure 3-12. Bands corresponding to
cytomix-treated cells (positive control) appeared darker than other bands, which
confirms that MAP kinase activation is detectable in hCMEC/D3 using our current
experimental protocol.
Our results indicate that JNK 1/2, ERK 1/2, and p38 are not activated in
hCMEC/D3 at 30 minutes following injury. Bands corresponding to p-JNK 1/2 were
detected in CM-treated cells, but not in uninjured and stretch-injured cells (Figure 312). Levels of p-ERK 1/2 (Figure 3-13; n=3), and p-38 (Figure 3-14; n=3) are not
significantly higher in injured hCMEC/D3 compared to uninjured cells. Thus MAP
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kinase does not seem to be activated in hCMEC/D3 at 30 minutes following a severe
concussive injury.
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Figure 3-12. MAP Kinase Phosphorylation in hCMEC/D3. Uninjured and injured
hCMEC/D3 were lysed in 1X SDS sample buffer at 30 minutes post-injury and
subsequently subjected to SDS-PAGE. hCMEC/D3 treated with cytomix (CM; 10
ng/mL TNF-α, IL-1β and IFN-γ) served as a positive control. Proteins were
transferred by Western blotting onto a PVDF membrane and probed with antibodies
against phosphorylated JNK 1/2 (p-JNK 1/2), phosphorylated ERK 1/2 (p-ERK 1/2)
or phosphorylated p38 (p-p38). GAPDH served as loading control. Protein bands
were visualized by chemiluminescence. Representative immunoblots from 3
independent experiments are shown above.
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Figure 3-13. Levels of phosphorylated ERK 1/2 in Injured hCMEC/D3. Western
blotting was performed to detect levels of phosphorylated ERK 1/2 (p-ERK 1/2) in
uninjured and concussed hCMEC/D3 at 30 minutes post-injury. Protein bands
corresponding to p-ERK 1/2 were quantified and standardized to the levels of the
loading control protein, GAPDH. Relative levels of p-ERK 1/2 are presented as the
optical density (O.D.) of p-ERK 1/2 over GAPDH (mean±SEM, n=3). Data were
collected from 3 independent experiments.
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Figure 3-14. Levels of phosphorylated p38 in Injured hCMEC/D3. Western
blotting was performed to detect levels of phosphorylated p38 (p-p38) in uninjured
and concussed hCMEC/D3 at 30 minutes post-injury. Protein bands corresponding to
p-p38 were quantified and standardized to the levels of the loading control protein,
GAPDH. Relative levels of p-p38 are presented as the optical density (O.D.) of p-p38
over GAPDH (mean±SEM, n=3). Data were collected from 3 independent
experiments.
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3.9 Activation of NF-κB was not Detected in Injured
hCMEC/D3
To investigate an alternative pathway that may be involved in hCMEC/D3
response to injury with subsequent up-regulation of CVEC pro-adhesive phenotype, we
assessed for relative NF-κB activation in hCMEC/D3 using a phospho-NF-κB p65
(Ser536) Sandwich ELISA. Relative NF-κB activation was assessed with respect to the
levels of phospho-NF-κB p65 in injured hCMEC/D3 compared to levels found in
uninjured cells at 1 hour post-injury. Experiments were conducted according to protocol
provided by the kit’s manufacturer (see Methods). Cellular levels of phospho- NF-κB
p65 were presented as the optical density (O.D.) reading at 450 nm.
Results from the phospho-NF-κB p65 ELISA indicated that relative levels of
phospho- NF-κB p65 in injured hCMEC/D3 were not significantly higher than levels in
uninjured cells (Figure 3-15; n=6). This suggests that at 1 hour post-injury, an elevated
level of phospho-NF-κB p65 is not involved in hCMEC/D3 following concussive
injury.
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Figure 3-15. NF-κB Activation in hCMEC/D3 Following Severe Concussive
Injury. Cellular activation of NF-κB was assessed with respect to phosphorylatedNF-κB p65 (Ser536) using Sandwich ELISA. Uninjured and concussed hCMEC/D3
were collected at 1 hour following injury and tested for phospho-NF-κB p65 using
the protocol provided with the ELISA kit. Detected phospho-NF-κB p65 were read
at 450 nm and presented as the assay’s optical density (O.D.; mean±SEM; n=6).
Data were collected from 6 independent experiments.
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Chapter 4

4

Discussion
Results from our experiments revealed that a severe concussive injury (55%

deformation) induces retraction of the HA monolayer. Mild (20% deformation) and
moderate (35% deformation) concussive injury appears to spare trauma-induced HA
retraction. Severe concussive injury does not induce HA detachment from monolayer.
Concussive injury also induces the activation of JNK 1/2 and ERK 1 in HA at 30
minutes following injury. Our data suggest that JNK 1/2 may be involved in mediating
injury-induced HA retraction. Inhibition of JNK in HA reduces HA retraction following
severe injury.
In contrast to HA, concussive injury to immortalized CVEC, hCMEC/D3, fails
to induce monolayer retraction. Thus, the same degree of injury to HA and hCMEC/D3
caused differential cellular response with respect to cellular morphology. Although
there does not seem to be obvious monolayer disruption, concussively injured
hCMEC/D3 exhibited an up-regulation of pro-adhesive phenotype. There were more
PMN adhering to injured hCMEC/D3 monolayer compared to uninjured cells. MAP
kinase JNK 1/2, ERK 1/2, and p38 were not activated in hCMEC/D3 at 30 minutes
following injury. Furthermore, NF-κB activation was also not detected in concussively
injured hCMEC/D3.
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4.1 Severe Concussive Injury Induces HA Retraction
HA grown on a fibronectin-coated culture well form a tightly packed confluent
monolayer, with few small gaps between cells. Following a severe concussive injury,
there is a change in the appearance of HA monolayer. Injured HA monolayer appears
retracted with the presence of large gaps or spaces between cells. In order to quantify
this phenomenon, we developed an assay to assess cell monolayer retraction. Confluent
HA were pre-stained with whole-cell fluorescent dye, 5, 6-carboxyfluoroscein diacetate
(CFDA), that allows for real-time fluorescent imaging of live HA cell culture. The
fluorescent stain provided a greater contrast between cells and the background (culture
membrane). Images of uninjured and injured CFDA-stained HA monolayer were
captured by fluorescent microscopy, and the percent of surface area covered in cells in
each picture were quantified using the ImageJ software. This provided a quantified
value of monolayer retraction (with respect to the percent of monolayer coverage).
The assessment of HA monolayer integrity revealed that a severe concussive
injury to primary human astrocytes result in an increase in monolayer retraction.
Despite the dramatic change in cell morphology, severely injured astrocytes remained
adherent to culture membrane after injury; we detected negligible amounts of detached
cells in culture media following injury. This suggests that membrane area that is absent
of cells following concussive injury to HA is likely due to a change in HA morphology,
as opposed to a mere detachment of cells from the membrane, for leaving gaps of space
throughout the monolayer.
Furthermore, we investigated whether HA monolayer retraction also occurs
following a less severe injury. Therefore, in addition to severe injury, we assessed the
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monolayer integrity of HA monolayer following a mild and moderate concussive
injury. Our data revealed that cellular retraction does not occur following a mild and
moderate concussive injury. Therefore, HA retraction seems dependent on the severity
of the injury and occurs only following severe concussive injury. Results from our
study correlates with earlier works that employed cultured primary rat astrocytes to
model TBI in vitro. Similar to the human primary astrocytes used in this study, rat
astrocytes exhibited cellular retraction following a severe concussive injury (55%
stretch) [9, 54]. Although retracted, rat astrocytes also appeared to remain adherent to
the culture membrane, as no significant cellular detachment occurred following injury
[9, 54].

4.2 MAP Kinase Activation in Injured HA
To assess for a potential mechanism mediating the change in HA morphology
following a severe concussive injury, we assessed for MAP kinase activation in HA
following injury. Activation of the MAP kinase pathways involves the phosphorylation
of their subunits, which allows for rapid signal transduction in response to stress or
injury [41]. Results from our study indicated that at 30 minutes following injury, JNK
1/2, as well as ERK 1 is activated in HA. In our experimental conditions, p38 does not
seem to be activated following severe stretch injury. These findings are in contrast to a
study using in vitro and in vivo rat models of TBI that noted the activation of ERK 1/2
and p38, whereas JNK phosphorylation remain unchanged [26, 37]. Variations between
our study and what has previously been reported may be due to the different types of
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trauma model used – we employed a stretch injury to mimic a biaxial force TBI, which
may induce a different cellular response than if other TBI models were used (i.e.
cortical impact and mechanical scratch injuries) [40]. Furthermore, our study employs
the use of primary human astrocytes rather than rat cells. Thus specific induction of
MAP kinase may be dependent on which cell models were used (i.e. humans versus
animal).
Based on the data obtained in our study, there are notable activations of JNK 1/2
in injured HA, which coincides with the appearance of monolayer retraction. JNK is
activated by many factors, including environmental stress, ischemic reperfusion injury,
genotoxins, pro-inflammatory cytokines, and mechanical stress [41]. The JNK
signaling pathway governs many cellular functions, including various gene
transcriptions, apoptosis and cell morphology [41]. MAP kinase has been reported to
mediate astrocyte swelling following TBI [33]. The use of various inhibitors, including
a JNK inhibitor SP600125, prior to injury significantly reduces rat astrocyte swelling
following injury. Furthermore, the JNK pathway has been implicated in the
maintenance of cytoskeletal structure in cells of the CNS [55]. Stability of the
microtubules in a cell plays a pivotal role in the maintenance of cell shape, and JNK
have been reported to be involved in regulating microtubule dynamics in neuronal cells
[55]. As such, we assessed whether HA monolayer retraction following a severe
concussive injury is mediated by JNK 1/2 activation.
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4.3 HA Retraction Mediated by JNK
To address the role of JNK 1/2 activation in HA retraction following a severe
concussive injury, we employed 2 commercially available selective JNK inhibitors,
SP600125 and SU3327. These 2 inhibitors selectively inhibit JNK using 2 different
mechanisms. SP600125 is a reversible, competitive JNK 1/2/3 inhibitor that interferes
with ATP binding to the JNK subunits [51]. SU3327 is a more recently developed
selective JNK inhibitor, which prevents the protein-protein interactions between JNK
and JNK Interacting Protein (JIP) [53]. In the absence of JNK inhibitors, concussive
injury to HA induced monolayer retraction. Pre-treatment of with JNK inhibitors prior
to injury reduced the extent of HA retraction following severe concussion. Similar
results were obtained using the two different JNK inhibitors, which strengthen the
suggestion that injury-induced change in HA morphology following a severe
concussive injury (i.e. monolayer retraction) is likely mediated by the JNK signaling
pathway.
The exact mechanism of how JNK mediates HA retraction and alter cellular
morphology following injury is not yet known. JNK may alter cellular morphology
directly by interacting with cytoskeleton-associated proteins, or indirectly by mediating
the activity of another protein that leads to a downstream change in cellular
cytoskeleton dynamics [44, 55]. In neurons, JNK 1 phosphorylates microtubuleassociated proteins, altering microtubule dynamics and in turn, cell morphology [55].
MAP kinase regulation of microtubule-associated proteins has also been implicated in
regulating microtubule cytoskeletons in non-neuron cells during various cellular events
[55]. JNK may also regulate cell morphology through its interaction with other
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signaling molecules. For example, ubiquitous protein kinase CK2 regulates the
phosphorylation of actin and myosin light chain proteins in astrocytes [44]. Activation
of CK2, which may be mediated by MAP kinase activities, alters the phosphorylation
of microtubule-associated proteins and induces cell contractions [44]. Changes to actin
filaments (i.e. actin filament assembly/disassembly) may be accompanied by
rearrangement of integrin-mediated focal adhesion to facilitate in modifications of cell
morphology (i.e. cell retraction) in astrocytes [45, 46]. Further investigations must be
conducted to determine the upstream and downstream mechanisms in JNK-mediated
HA retraction following severe concussive injury.

4.4 Severe Concussive Injury Fails to Induce hCMEC/D3
Retraction
Human immortalized CVEC, hCMEC/D3 grown on a fibronectin-coated culture
well form a dense, confluent cell monolayer with no gaps between cells.
Morphologically, this mimics CVEC in vivo, which form a tight monolayer on the
luminal side of the microvasculature that restricts the movements of substances across
the blood vessel [47]. Following a severe concussive injury with a 55% membrane
deformation, hCMEC/D3 monolayer appears intact and does not exhibit any sign of
retraction. This is in contrast to HA monolayer, which appears dramatically retracted
following the same degree of injury to hCMEC/D3. This suggests that HA are more
severely affected by concussive injury than hCMEC/D3. One caveat in our study is the
use of immortalized CVEC, which potentially may explain why hCMEC/D3 are less
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sensitive to monolayer changes than the primary astrocytes. However, a study that
employed the use of primary rabbit and bovine endothelial cells found that endothelial
cells were much more resistant to a stretch injury and require a greater degree of injury
to produce the same extent of injury than astrocytes [54]. Endothelial cells also
appeared to recover more rapidly following injury than astrocytes and neural glial cells
[54]. Therefore, it is more likely that the degree of injury applied to hCMEC/D3 in our
experimental approach simply were not enough to induce a physical disruption of
CVEC monolayer. Although the concussively injured hCMEC/D3 do not appear to be
morphologically altered, we assessed for a cellular response to injury with respect to
PMN adhesion to injured CVEC monolayer.

4.5 Severe Concussive Injury Up-regulates hCMEC/D3
Pro-adhesive Phenotype
In a healthy individual, there are little interactions between CVEC lining the
microvasculature and circulating immune cells [3]. As a result, migration across the
endothelium is restricted by the BBB and very few immune cells are found in the CNS
[3]. CVEC play a role in mediating inflammation in CNS with respect to its interactions
with circulating immune cells such as PMN [3]. Under a pathological condition, there
may be an up-regulation of endothelial cell pro-adhesive phenotype marked by induced
expression of surface adhesion molecules [3]. As more PMN adhere to CVEC, there is
a greater opportunity for PMN to migrate across the microvasculature and accumulate
in the brain parenchyma.
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To address the potential role of CVEC in facilitating the accumulation of PMN
following a TBI in humans, we assessed whether there is up-regulation of pro-adhesive
phenotype in hCMEC/D3 following a severe concussive injury. Using a radioactive
labeled PMN, we observed increase PMN adhering to injured hCMEC/D3 monolayer
relative to uninjured cell monolayer. Thus a severe concussive injury induces proadhesive phenotype. This is likely due to increased expression of adhesion molecules,
such as E-selectin, intercellular adhesion molecules (ICAM-1, ICAM-2) or vascular cell
adhesion molecule (VCAM-1), on the surface of endothelial cells that can interact with
selectin-receptors and integrins (e.g. β2 integrins) expressed on the surface of PMN [11,
28]. The exact signaling pathways involved in the up-regulation of CVEC pro-adhesive
phenotype following a mechanical injury are not yet known. In this study, we assessed
the potential involvement of MAP kinase and NF-κB in hCMEC/D3 following injury.

4.6 Activation of MAP Kinase and NF-κB were not
Detected in Injured hCMEC/D3
Levels of phosphorylated ERK 1/2, JNK 1/2 and p38 were assessed in uninjured
and injured hCMEC/D3 to assess for MAP kinase activation. Results obtained from our
experiments revealed that ERK 1/2, JNK 1/2 and p38 are not activated in concussively
injured hCMEC/D3. This is in contrast to HA, which exhibited activation of ERK 1 and
JNK 1/2 following injury. Typically, MAP kinase activation occur rapidly following an
insult (i.e. within minutes), therefore MAP kinase activation was assessed at 30 minutes
following injury. However, if MAP kinase activation occurs later in injured
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hCMEC/D3, it would not be detected with our current experimental approach. It is
more likely that another signaling pathway is involved in mediating injury-induced
hCMEC/D3 response.
One of the major signaling pathways involved in a cellular response to stress is
the transcription factor, NF-κB [38]. NF-κB is activated by various pathogenic
stimulants and plays a key role in regulating the inflammatory process [38]. Activated
NF-κB has been implicated in up-regulating the transcription of surface adhesion
molecules in endothelial cells [28]. In our study, relative NF-κB activation in injured
hCMEC/D3 compared to uninjured cells were measured at 1 hour following injury,
with respect to phosphorylated NF-κB p65 (Ser 536). However, under our experimental
condition, we failed to detect elevated levels of phosphorylated NF-κB p65 in injured
hCMEC/D3. The activity of the NF-κB pathway is complex and our study was limited
to assessing only one measurement of NF-κB activation. It is possible that traumainduced hCMEC/D3 response is not via an increase in phosphorylation of NF-κB p65
(Ser 536). Further studies must be conducted to confirm whether NF-κB plays a role in
hCMEC/D3 response to a traumatic injury. Up-regulation of NF-κB and the subsequent
genes translated upon its activation depend on the formation of subunit homodimers or
heterodimers and whether they are translocated to the nucleus [38]. Furthermore, NFκB subunits may also interact with other signaling pathways, such as AP-1 or MAP
kinases, in mediating a cellular response following injury [42].
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4.7 Clinical Relevance
Results of our study revealed that a severe concussive injury (i.e. TBI) induces
astrocyte retraction. In vivo, astrocyte retraction may translate to a loss in the
intimate cell-cell contact between perivascular astrocyte endfeet and CVEC, as
well as the enlargement of perivascular space. Uncoupling of astrocyte-endothelial
cell units may result in the loss of communications between neurons and the BBB
[13]. This may impair the astrocytes from regulating capillary vasodilation/
vasoconstriction for a proper hyperemia. As a result, increased neuronal activity may
not be accompanied with the proper change in local blood flow to match the metabolic
demand [19]. Imbalanced energy supply to the brain may lead to greater damage to the
brain tissue and further complicate a TBI.
Our data revealed that a severe concussive injury alone is not enough to induce
CVEC monolayer disruption in an isolated system. It is possible that dysfunction to the
cerebral endothelium is secondary to trauma, rather than from the initial mechanical
injury from the traumatic impact itself. Post-traumatic breakdown of the BBB (with
respect of the CVEC) may be mediated by astrocytes. As mentioned above, uncoupling
of astrocyte endfeet from endothelial cells may prevent astrocytes from inducing a tight
cerebrovascular endothelium [13]. As the capillaries become “leaky”, components of
the circulation are no longer restricted in the vasculature and can accumulate in the
brain parenchyma [3, 14]. Movements of plasma proteins, ions, and water into the CNS
lead to the formation of vasogenic edema, or brain swelling [16]. Indeed, clinical
evaluations have reported that diffused brain swelling (DBS) is a common complication
following a TBI [21, 23]. Post-mortem examinations of TBI brain victims revealed that
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brains with moderate edema had enlarged perivascular space and distended astrocyte
processes [21]. Individuals with severe edema exhibited the absence of perivascular
astrocyte end-feet surrounding the microvessels and large perivascular space beyond
the basement membrane of the cerebral vasculature [21]. Thus the integrity of the
support offered by astrocytic endfeet surrounding the cerebral blood vessels seem to
correlate with the formation of post-traumatic edema.
Although the concussive injury itself does not appear to induce cerebral
endothelium dysfunction, we assessed for another aspect in which a concussive injury
may alter CVECs. TBI can elicit an inflammatory response that may worsen neural
injuries [7, 11]. Rat models of TBI revealed accumulation of PMN in intracranial space
within hours following injury [24, 25]. In our in vitro human TBI model, we observed
increased PMN adhesion to injured hCMEC/D3 monolayer. Up-regulation of CVEC
pro-adhesive phenotype (i.e. increased CVEC-PMN interactions) can facilitate the
migration of PMN across the endothelium [7]. However, the mechanisms involved in
the up-regulation of endothelial cell pro-adhesive phenotype in hCMEC/D3 following
concussive injury and its implications in the development of TBI pathology is yet to be
explained and require further investigations.

4.8 Limitations and Future Directions
Our study employed the use of Cell Injury Controller II to model a TBI in vitro.
This machine induces a uniform, biaxial stretch injury to a cell monolayer grown on a
flexible support to mimic an acceleration/deceleration-type of traumatic injury [9]. In
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an actual trauma, brain tissues typically experience multiple forms of injuries as
opposed to only a single “traumatic blow”. Depending on the type and magnitude of the
TBI, different parts of the brain may experience different injuries. Although the
mechanical injury used in our experimental condition may represent a simplified model
of TBI, the Cell Injury Controller II produces a well-controlled, repeatable injury. The
homogeneity of injury in the experiments reduces the technical variability that may
arise in our experimental assays.
To assess how a mechanical trauma affects the BBB, we employed the use of
primary human astrocytes, HA, and immortalized CVEC, hCMEC/D3. Due to a limited
availability of primary human cerebrovascular endothelial cells, we used wellcharacterized immortalized cell line, hCMEC/D3. Although there are concerns that
immortalized cells may differ from its primary counterpart, studies have shown that
hCMEC/D3 maintain the expression of key BBB phenotypes, such as the formation of
intercellular tight junctions and expressions of surface adhesion molecules [47, 48].
Furthermore, our study assessed astrocytes and endothelial cells in a separate culture. In
vivo, astrocytes and endothelial cells are found in close proximity and induce BBBspecific phenotypes in one another [15]. As cells are grown and injured separately, we
are limited from observing how astrocytes and endothelial cells affect one another.
However, separate assessment of each component of the BBB is useful to determine
specific astrocyte and endothelial cell response following trauma. In addition, our
studies strictly employed the use of human-derived tissues. Therefore, results of this
study are highly translational for further understanding of TBI pathology in humans.
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Lastly, our experiments were done entirely in vitro. In contrast, TBIs in vivo are
highly heterogeneous and may invoke complex secondary complications beyond the
initial trauma, including hypoxia/ischemia, metabolic imbalance, and inflammation [2,
10]. Such complex conditions were not replicated in our experimental approach.
Secondary insults associated with TBI may further complicate the cellular response
post-injury and requires further investigations.
In future studies, astrocyte and CVEC response to a concussive injury in vitro
should be assessed in co-culture to further address how injured cells affect one another.
Isolated astrocytes exhibited trauma-induced cellular retraction. It would be valuable to
assess whether a similar phenomenon occurs in a co-cultured system and how CVEC
respond to astrocyte retraction. For instance, we can assess CVEC monolayer
permeability using a Texas Red Dextran assay to determine the “tightness” of CVEC
monolayer following concussive injury and astrocyte retraction [56]. As CVEC
monolayer permeability increases, more Texas Red Dextran would go through the cells.
Furthermore, it would be interesting to assess whether trauma-induced cellular injury
and dysfunction is worsened in a co-cultured system. Astrocytes and CVEC release
factors, such as bradykinin and IL-6, in response to stress and injury, which may induce
a greater cellular response in one another [13]. Whether such response is protective or
detrimental to further injuries must be determined. For further investigations, animal
models may also be employed to assess whether trauma-induced astrocyte process
retraction occurs in vivo. Results from our study suggest that MAP kinase is involved in
mediating astrocyte retraction following injury, and selective MAP kinase inhibitor
reduced trauma-induced retraction. If similar results were to be found in an animal
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model, we can determine whether minimizing astrocyte endfeet retractions can reduce
secondary TBI complications (i.e. dysfunctional cerebral blood flow regulation, brain
swelling) and improve the long-term outcomes of TBI.
Results from our study revealed that a severe concussive injury induces JNKmediated astrocyte retractions. However, we have yet to fully explain exactly how JNK
regulates astrocyte morphology. Upstream of JNK activation in astrocytes following
injury likely involves ATP/purinergic receptors, which has been implicated in
mediating cellular response following stretch injury in rat astrocytes [37]. Effects of
JNK on astrocyte morphology must also be further investigated. Following severe
injury, JNK may induce the activation of other signaling molecules, such as CK2,
which regulates cellular actin-tubulin cytoskeleton network [44]. JNK can also directly
affect cellular morphology by phosphorylating microtubule-associated proteins that
maintains the cytoskeleton stability in cells [55].
Under our experimental conditions, severe injury alone fails to induce CVEC
monolayer disruption. However, CVEC pro-adhesive phenotype was up-regulated
following injury, as increased PMN adhesion to injured cells were observed. We have
yet to determine which surface adhesion molecules are expressed in injured CVEC and
which signaling pathways are involved in mediating the cellular response. Increased
expression of surface adhesion molecules E-Selectin, VCAM and ICAM may be
determined at a transcriptional level (with real-time polymerase chain reaction; RTPCR) or at a protein-level (with Western Blotting). Although we failed to detect NF-κB
activation in injured hCMEC/D3 with respect to elevated cellular phospho-p65 levels,
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we must confirm our finding using other means of measuring NF-κB activation (i.e.
levels of I-κB degradation, p50 and p65 nuclear translocation) [39].
Lastly, we observed that treatments with selective JNK inhibitors reduced the
severity of astrocyte retraction. With further investigations, this can lead to a potential
therapeutic method for reducing the development of complication and improve the
long-term outcome of TBI.
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